These findings highlight MAGI3 as a novel tumor suppressor in ccRCC and indicate the importance of the ACE2/Ang-(1-7)/MAS axis in Sunitinib resistance in ccRCC. This evidence concerns the gene ACE2 and nonpapillary renal cell carcinoma.